SCIENTIFIC BACKGROUND

AIP, AKT1, ANKRD26, AP2S1, APC, ATM, AXIN2, BAP1, BARD1, BLM, BMPR1A, BRCA1, BRCA2, BRIP1, BUB1, CASR, CDC73, CDH1, CDH23, CDK12, CDK4, CDKN1A, CDKN1B, CDKN2A, CDKN2B, CDKN2C, CEBPA, CHEK1, CHEK2, CTNNA1, DDB2, DDX41, DICER1, DLST, EGLN1, EPAS1, EPCAM, EPOR, ERCC2, ERCC3, ERCC4, ERCC5, ETV6, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, FH, FLCN, GALNT12, GATA2, GCM2, GNA11, GNAS, GPR101, GREM1, HOXB13, KIF1B, KIT, KITLG, LZTR1, MAD2L2, MAX, MC1R, MEN1, MET, MITF, MLH1, MLH3, MRE11, MSH2, MSH3, MSH6, MUTYH, NBN, NF1, NF2, NTHL1, PALB2, PDGFRA, PIK3CA, PMS1, PMS2, POLD1, POLE, POLH, POT1, PRKAR1A, PTCH1, PTCH2, PTEN, RAD50, RAD51, RAD51B, RAD51C, RAD51D, RAD54L, RB1, RECQL, RECQL4, RET, RFWD3, RNF43, RPS20, RUNX1, SDHA, SDHAF2, SDHB, SDHC, SDHD, SLC25A11, SLX4, SMAD4, SMARCA4, SMARCB1, SMARCE1, SPRED1, SRP72, STK11, SUFU, TERT, TMEM127, TP53, TSC1, TSC2, UBE2T, VHL, WT1, XPA, XPC, XRCC2, XRCC3

 

The comprehensive cancer panel analyses 54 genes associated with >30 cancer types spanning across 10 organs and systems including breast, ovary, colon, endocrine system, pancreas, stomach, prostate, skin, kidney and nervous system/brain. The outcome of the test can be a risk estimation of developing cancer from a genetic cause. If a person has an estimated high cancer risk, certain actions can be taken to reduce the likelihood of developing the cancer such as undergoing routine monitoring. Additionally, family members can be informed and encouraged to have a test.

 

If a pathogenic variant is identified in one of the associated genes, the risk of developing one of these syndromes is higher as compared to the average risk in the general population. Conversely, if a pathogenic variant is not identified, this does not preclude the possibility of developing cancer from unknown genetic factors or sporadic causes.

 

Our genetic counsellors can provide a detailed interpretation of the diagnostic report and advice on preventative measures and surveillance recommendations.

 
Disorders included
 

  • Basal Cell Carcinoma Syndrome/Gorlin-Goltz Syndrome
  • Birt-Hogg-Dub Syndrome
  • Breast Cancer
  • Colorectal Cancer
  • Constitutional Mismatch Repair Deficiency
  • DICER1 Syndrome
  • Familial Adenomatous Polyposis
  • Fanconi Anemia
  • Gastric Cancer
  • Hereditary Mixed Polyposis
  • Hyperparathyroidism-Jaw Tumor Syndrome
  • Juvenile Polyposis Syndrome
  • Leiomyomatosis and Renal Cell Cancer
  • Li-Fraumeni Syndrome
  • Lynch Syndrome
  • Medullary Thyroid Carcinoma
  • Melanoma
  • Multiple Endocrine Neoplasia (MEN) 1
  • MEN2
  • MEN4
  • Neurofibromatosis, Type I
  • Ovarian Cancer
  • Pancreatic Cancer
  • Paragangliomas
  • Parathyroid Carcinoma
  • Peutz-Jeghers Syndrome
  • Pheochromocytoma
  • PTEN Hamartoma Tumor Syndrome
  • Renal Cell Carcinoma
  • Sessile Serrated Polyposis Cancer Syndrome
  • Tumor Predisposition Syndrome
  • Von Hippel-Lindau Syndrome

GENES

AIP, AKT1, ANKRD26, AP2S1, APC, ATM, AXIN2, BAP1, BARD1, BLM, BMPR1A, BRCA1, BRCA2, BRIP1, BUB1, CASR, CDC73, CDH1, CDH23, CDK12, CDK4, CDKN1A, CDKN1B, CDKN2A, CDKN2B, CDKN2C, CEBPA, CHEK1, CHEK2, CTNNA1, DDB2, DDX41, DICER1, DLST, EGLN1, EPAS1, EPCAM, EPOR, ERCC2, ERCC3, ERCC4, ERCC5, ETV6, FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, FH, FLCN, GALNT12, GATA2, GCM2, GNA11, GNAS, GPR101, GREM1, HOXB13, KIF1B, KIT, KITLG, LZTR1, MAD2L2, MAX, MC1R, MEN1, MET, MITF, MLH1, MLH3, MRE11, MSH2, MSH3, MSH6, MUTYH, NBN, NF1, NF2, NTHL1, PALB2, PDGFRA, PIK3CA, PMS1, PMS2, POLD1, POLE, POLH, POT1, PRKAR1A, PTCH1, PTCH2, PTEN, RAD50, RAD51, RAD51B, RAD51C, RAD51D, RAD54L, RB1, RECQL, RECQL4, RET, RFWD3, RNF43, RPS20, RUNX1, SDHA, SDHAF2, SDHB, SDHC, SDHD, SLC25A11, SLX4, SMAD4, SMARCA4, SMARCB1, SMARCE1, SPRED1, SRP72, STK11, SUFU, TERT, TMEM127, TP53, TSC1, TSC2, UBE2T, VHL, WT1, XPA, XPC, XRCC2, XRCC3
How to order

LATEST ARTICLES

We're thrilled to share the results of Medicover Genetics essay competition for high school students as well as the two winning essays. This competit...

Read more

Cystic fibrosis (CF) is a life-threatening, progressive, inherited condition that causes severe damage to the body, primarily affecting the organs of...

Read more

Down syndrome is a genetic condition caused by the presence of an extra copy of chromosome 21. It affects physical growth, facial features, and cogni...

Read more

Every year on April 25th, DNA Day celebrates the discovery of DNA’s double helix and the advances we’ve made in understanding genetics. D...

Read more

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric patients f...

Read more

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an advanced ...

Read more

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more